News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
740,569 Results
Type
Article (47851)
Company Profile (322)
Press Release (692386)
Multimedia
Podcasts (97)
Webinars (19)
Section
Business (209684)
Career Advice (2203)
Deals (36115)
Drug Delivery (124)
Drug Development (82640)
Employer Resources (194)
FDA (16561)
Job Trends (15329)
News (353670)
Policy (33428)
Tag
Academia (2748)
Academic (2)
Accelerated approval (24)
Adcomms (27)
Allergies (125)
Alliances (51146)
ALS (162)
Alzheimer's disease (1674)
Antibody-drug conjugate (ADC) (275)
Approvals (16738)
Artificial intelligence (490)
Autoimmune disease (119)
Automation (33)
Bankruptcy (367)
Best Places to Work (11827)
BIOSECURE Act (21)
Biosimilars (176)
Biotechnology (199)
Bladder cancer (148)
Brain cancer (52)
Breast cancer (597)
Cancer (4468)
Cardiovascular disease (368)
Career advice (1865)
Career pathing (38)
CAR-T (273)
CDC (50)
Celiac Disease (1)
Cell therapy (711)
Cervical cancer (36)
Clinical research (69791)
Collaboration (1528)
Company closure (4)
Compensation (1042)
Complete response letters (48)
COVID-19 (2775)
CRISPR (85)
C-suite (719)
Cystic fibrosis (137)
Data (5751)
Decentralized trials (2)
Denatured (40)
Depression (115)
Diabetes (462)
Diagnostics (6761)
Digital health (38)
Diversity (12)
Diversity, equity & inclusion (48)
Drug discovery (231)
Drug pricing (175)
Drug shortages (29)
Duchenne muscular dystrophy (215)
Earnings (90624)
Editorial (54)
Employer branding (25)
Employer resources (166)
Events (120208)
Executive appointments (968)
FDA (19333)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (20)
Funding (1380)
Gene editing (188)
Generative AI (42)
Gene therapy (561)
GLP-1 (966)
Government (4791)
Grass and pollen (6)
Guidances (377)
Healthcare (19243)
HIV (49)
Huntington's disease (42)
IgA nephropathy (77)
Immunology and inflammation (237)
Immuno-oncology (37)
Indications (76)
Infectious disease (3023)
Inflammatory bowel disease (184)
Inflation Reduction Act (15)
Influenza (104)
Intellectual property (214)
Interviews (349)
IPO (16835)
IRA (50)
Job creations (3852)
Job search strategy (1575)
Kidney cancer (15)
Labor market (85)
Layoffs (569)
Leadership (32)
Legal (8105)
Liver cancer (89)
Longevity (12)
Lung cancer (619)
Lymphoma (353)
Machine learning (38)
Management (63)
Manufacturing (693)
MASH (156)
Medical device (13846)
Medtech (13883)
Mergers & acquisitions (20247)
Metabolic disorders (1173)
Multiple sclerosis (145)
NASH (22)
Neurodegenerative disease (287)
Neuropsychiatric disorders (70)
Neuroscience (2784)
NextGen: Class of 2025 (6723)
Non-profit (4670)
Now hiring (62)
Obesity (550)
Opinion (271)
Ovarian cancer (151)
Pain (179)
Pancreatic cancer (195)
Parkinson's disease (259)
Partnered (32)
Patents (451)
Patient recruitment (400)
Peanut (56)
People (60592)
Pharmaceutical (72)
Pharmacy benefit managers (26)
Phase I (21748)
Phase II (30698)
Phase III (22900)
Pipeline (3866)
Policy (274)
Postmarket research (2644)
Preclinical (9501)
Press Release (72)
Prostate cancer (217)
Psychedelics (46)
Radiopharmaceuticals (270)
Rare diseases (728)
Real estate (6272)
Recruiting (76)
Regulatory (24420)
Reports (62)
Research institute (2531)
Resumes & cover letters (376)
Rett syndrome (23)
RNA editing (13)
RSV (75)
Schizophrenia (139)
Series A (230)
Series B (172)
Service/supplier (14)
Sickle cell disease (95)
Special edition (22)
Spinal muscular atrophy (156)
Sponsored (41)
Startups (3812)
State (2)
Stomach cancer (17)
Supply chain (100)
Tariffs (80)
The Weekly (55)
Vaccines (986)
Venture capital (78)
Weight loss (362)
Women's health (76)
Worklife (19)
Date
Today (106)
Last 7 days (538)
Last 30 days (2411)
Last 365 days (30811)
2025 (30329)
2024 (35945)
2023 (40860)
2022 (51925)
2021 (56499)
2020 (54898)
2019 (47645)
2018 (35936)
2017 (33084)
2016 (32665)
2015 (38767)
2014 (32375)
2013 (27536)
2012 (29798)
2011 (30535)
2010 (29032)
Location
Africa (810)
Alabama (79)
Alaska (7)
Arizona (298)
Arkansas (14)
Asia (40655)
Australia (6683)
California (10506)
Canada (3118)
China (991)
Colorado (445)
Connecticut (449)
Delaware (311)
Europe (88692)
Florida (1550)
Georgia (341)
Hawaii (3)
Idaho (62)
Illinois (801)
India (56)
Indiana (503)
Iowa (21)
Japan (374)
Kansas (124)
Kentucky (38)
Louisiana (25)
Maine (70)
Maryland (1323)
Massachusetts (7636)
Michigan (322)
Minnesota (609)
Mississippi (6)
Missouri (123)
Montana (30)
Nebraska (26)
Nevada (114)
New Hampshire (75)
New Jersey (2849)
New Mexico (30)
New York (2813)
North Carolina (1409)
North Dakota (10)
Northern California (5030)
Ohio (310)
Oklahoma (20)
Oregon (38)
Pennsylvania (2149)
Puerto Rico (19)
Rhode Island (45)
South America (1175)
South Carolina (58)
South Dakota (1)
Southern California (4066)
Tennessee (165)
Texas (1633)
United States (37766)
Utah (314)
Vermont (1)
Virginia (243)
Washington D.C. (83)
Washington State (862)
West Virginia (4)
Wisconsin (106)
Wyoming (2)
740,569 Results for "kannalife sciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Kannalife Secures Funding of $1.49 Million from The Michael J. Fox Foundation for Parkinson’s Research
Kannalife Sciences, Inc. is pleased to announce it has been awarded funding of $1,493,409 million from The Michael J. Fox Foundation for Parkinson’s Research.
June 25, 2024
·
4 min read
Press Releases
CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025
November 10, 2025
·
3 min read
Press Releases
SK Life Science, Inc. Announces Publication of C035 Study Analyses in Epilepsia and Seizure
November 18, 2025
·
10 min read
Press Releases
Britannia Life Sciences Inc. Enters into $11.3 Million Share Exchange Agreement with McEwen Inc. and Britannia Mining Solutions Inc.
November 3, 2025
·
4 min read
Business
Basel Life Sciences Scene Embraces International Companies, Startups
The Basel area is home to over 800 life sciences companies, including Novartis and Roche, according to nonprofit Basel Area Business & Innovation. The nonprofit’s CEO and a BeOne Medicines executive discuss the location’s evolution, advantages and future.
November 6, 2025
·
6 min read
·
Angela Gabriel
Press Releases
Britannia Life Sciences Inc. Delays Closing of Debenture Offering
September 19, 2025
·
1 min read
Press Releases
SK Life Science, Inc. to Present 10 Posters with New Cenobamate Data, Including a Late-Breaker, at the 2025 American Epilepsy Society (AES) Annual Meeting
November 24, 2025
·
11 min read
Job Trends
$17M in Tax Incentives Will Add 800 Life Sciences Jobs This Year in Massachusetts
Of the 25 companies receiving tax incentives in Massachusetts, 23 will add jobs outside of Boston and Cambridge. Medtronic, which is receiving the largest award, will create 220 roles in Billerica. Other recipients include AbbVie, Dyne Therapeutics and Viridian Therapeutics.
October 24, 2025
·
2 min read
·
Angela Gabriel
Press Releases
CV Sciences, Inc. Reports Second Quarter 2025 Financial Results
August 13, 2025
·
13 min read
Business
Washington’s Life Sciences Scene Moves Beyond Research Roots
Washington has had notable life sciences job growth over the past 10 years, according to a Life Science Washington report. The association’s CEO and a biopharma CEO discuss what makes the state stand out, including its talent pool, AI leadership and entrepreneurship support.
August 21, 2025
·
5 min read
·
Angela Gabriel
1 of 74,057
Next